Publications by authors named "D L Churchill"

Cysteine (Cys) detection is recognized as an essential element in this investigation due to the critical function of Cys in several physiological processes in living organisms. A new NIR fluorescent probe SNC-Cys has been synthesized by incorporating a five-membered malononitrile derivatized ring as an electron withdrawing group, and a methacryloyl group detection moiety for cysteine. After adding Cys, SNC-Cys shows an emission of 654 nm and further works as a "Turn-on" probe via ICT photomechanism.

View Article and Find Full Text PDF

Objective: To investigate whether induction/augmentation of labor in pregnant women with anemia increases the risk of postpartum hemorrhage (PPH) and whether this risk varied by indications for labor induction/augmentation and by anemia severity in pregnancy.

Methods: In a prospective cohort study of 9420 pregnant women from 13 hospitals across India, we measured hemoglobin concentrations at recruitment (≥28 weeks of gestation) and blood loss after childbirth during follow-up and collected clinical information about PPH. Clinical obstetric and childbirth information at both visits were extracted from medical records.

View Article and Find Full Text PDF

Anaemia in pregnancy is a global problem of significance in all settings. The most common cause is iron deficiency. Large numbers of women are affected, ranging up to 25-30% antenatally and 20-40% postnatally.

View Article and Find Full Text PDF

This study introduces a novel fluorescence 'turn-on' chemosensor, FHDA, based on a trans-Ferulic acid Schiff-base derivative. FHDA stands out as a highly selective and sensitive tool for the fluorescent detection of Al3 with the fluorescence 'turn-on' effect. FHDA exhibits a strong CHEF effect and ICT upon complexation with Al in a 1:2 binding stoichiometry.

View Article and Find Full Text PDF
Article Synopsis
  • - Oral iron is the primary treatment for iron deficiency anemia during pregnancy, and a pilot randomized trial was conducted to assess different dosing schedules (daily, every other day, and three times a week) on various outcomes in non-anemic pregnant women.
  • - Of the 300 participants, overall adherence to the supplementation was 82.5%, with better adherence in the alternate day and three times a week groups (62% and 61%, respectively) compared to the daily group (47%).
  • - Results indicated that the daily iron dosing may help maintain hemoglobin levels better, but many reported side effects overlapped with typical pregnancy symptoms. More extensive trials are needed to confirm the benefits of oral iron supplementation for preventing iron deficiency anemia.
View Article and Find Full Text PDF